U.S. flag

An official website of the United States government

NM_198253.3(TERT):c.2110C>T (p.Pro704Ser) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Feb 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000520116.13

Allele description [Variation Report for NM_198253.3(TERT):c.2110C>T (p.Pro704Ser)]

NM_198253.3(TERT):c.2110C>T (p.Pro704Ser)

Gene:
TERT:telomerase reverse transcriptase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p15.33
Genomic location:
Preferred name:
NM_198253.3(TERT):c.2110C>T (p.Pro704Ser)
HGVS:
  • NC_000005.10:g.1279311G>A
  • NG_009265.1:g.20737C>T
  • NM_001193376.3:c.2110C>T
  • NM_198253.3:c.2110C>TMANE SELECT
  • NP_001180305.1:p.Pro704Ser
  • NP_937983.2:p.Pro704Ser
  • NP_937983.2:p.Pro704Ser
  • LRG_343t1:c.2110C>T
  • LRG_343:g.20737C>T
  • LRG_343p1:p.Pro704Ser
  • NC_000005.9:g.1279426G>A
  • NM_198253.2:c.2110C>T
  • NR_149162.3:n.2189C>T
  • NR_149163.3:n.2189C>T
  • O14746:p.Pro704Ser
Protein change:
P704S; PRO704SER
Links:
UniProtKB: O14746#VAR_068793; OMIM: 187270.0014; dbSNP: rs199422297
NCBI 1000 Genomes Browser:
rs199422297
Molecular consequence:
  • NM_001193376.3:c.2110C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198253.3:c.2110C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_149162.3:n.2189C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_149163.3:n.2189C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000617543GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Feb 22, 2022)
germlineclinical testing

Citation Link,

SCV003840113Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Likely pathogenic
(Oct 14, 2022)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000617543.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Observed in individuals with TERT-related disorders in published literature (Du 2009, Batista 2011); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30523342, 23901009, 18042801, 18635888, 23538340, 18931339, 27418648, 21602826, 28099038)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV003840113.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.2110C>T sequence change in exon 5 results in an amino acid change, p.Pro704Ser. The p.Pro704Ser change affects a poorly conserved amino acid residue located in a domain of the TERT protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Pro704Ser substitution. This sequence change has been reported in the homozygous state in two individuals with dyskeratosis congenital (PMID: 18042801, 18931339). It has also been described in the heterozygous state in three individuals from one family with pulmonary fibrosis and one individual with aplastic anemia (PMID: 1863588, 18931339). Multiple studies have found that the p.Pro704Ser change results in reduced telomerase activity (PMID: 18042801, 23901009. 18931339). This sequence change has been described in the gnomAD database in 2 individuals which corresponds to a population frequency of 0.0009% (dbSNP rs199422297). Based on these evidences this sequence change is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024